ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Malignant Carcinoid Syndrome

Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingCCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
2.RecruitingFR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
3.RecruitingBB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors
Conditions: adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ...
4.RecruitingBevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Conditions: recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
5.RecruitingStudy Evaluating SOM230 in Patients with Metastatic Carcinoid Tumors
Condition: Carcinoid Tumors

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act